Tenascin-C-Matrix Metalloproteinase-3 Phenotype and the Risk of Tendinopathy in High-Performance Athletes: A Case–Control Study

<b>Background/Objectives:</b> Tendon structure is predominantly composed of the extracellular matrix (ECM), and genetic variants in non-collagenous ECM components may influence susceptibility to tendinopathy. We investigated the potential influence of single nucleotide polymorphisms (SNPs) in fibrillin-2 (<i>FBN2</i>), tenascin-C (<i>TNC</i>), and matrix metalloproteinase-3 (<i>MMP3</i>) on the tendon regeneration failure phenotype and impact on the susceptibility to tendinopathy in Brazilian high-performance athletes. <b>Methods:</b> This case-control study was conducted with 397 high-performance athletes from different sports modalities (197 tendinopathy cases and 200 controls), and they were analyzed by validated TaqMan<sup>TM</sup> SNP genotyping assays of the SNPs <i>FBN2</i> (rs331079), <i>TNC</i> (rs2104772), and <i>MMP3</i> (rs591058). <b>Results:</b> Out of the 197 tendinopathy cases, 63% suffered from chronic tendon pain and 22% experienced more than three episodes of disease manifestation. The <i>TNC</i>-rs2104772-<i>A</i> allele was significantly associated with tendinopathy (OR: 1.4; 95% CI: 1.1-1.8), while athletes carrying the <i>MMP3</i>-rs591058-<i>T</i> allele were linked to an increased risk of more episodes of disease manifestation (OR: 1.7; 95% CI: 1.1-2.8). The <i>TNC-MMP3</i> tendon regeneration failure phenotype (<i>TNC-A/MMP3-T</i>) was associated with an increased risk of tendinopathy (OR: 1.4; 95% CI: 1.1-2.0) and episodes of disease manifestation (OR: 2.0; 95% CI: 1.2-3.5). Athletes with tendinopathy who had the <i>TNC-A/MMP3-T</i> interaction were more prone to experiencing more than three disease exacerbations (OR: 4.3; 95% CI: 1.8-10.5) compared to <i>TNC-A/TNC-C</i>. <b>Conclusions:</b> This study suggests that rs2104772 and rs591058 SNPs could be involved in the tendon regeneration failure phenotype and may influence the molecular mechanism related to the regulation of the tendon ECM during training workload.

Authors

Institutions

Publication Details

Journal
Diagnostics
Published
2024-11-05
DOI
https://doi.org/10.3390/diagnostics14222469
Citations
4
Primary Topic
Tendon Structure and Treatment
Type
article
Field-Weighted Citation Impact
1.91

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tenascin-C-Matrix Metalloproteinase-3 Phenotype and the Risk of Tendinopathy in High-Performance Athletes: A Case–Control Study

Rui Medeiros, Valéria Tavares, Daniel Escorsim Machado, Francisca Dias et al.
4 citations
Diagnostics
Tendon Structure and Treatment
1.91
article

Tenascin-C-Matrix Metalloproteinase-3 Phenotype and the Risk of Tendinopathy in High-Performance Athletes: A Case–Control Study

Rui Medeiros, Valéria Tavares, Daniel Escorsim Machado, Francisca Dias, Lucas Rafael Lopes, Marcus Vinícius Galvão Amaral, Rodrigo Araújo Goes, Jamila Alessandra Perini
article en
4 citations

Abstract

<b>Background/Objectives:</b> Tendon structure is predominantly composed of the extracellular matrix (ECM), and genetic variants in non-collagenous ECM components may influence susceptibility to tendinopathy. We investigated the potential influence of single nucleotide polymorphisms (SNPs) in fibrillin-2 (<i>FBN2</i>), tenascin-C (<i>TNC</i>), and matrix metalloproteinase-3 (<i>MMP3</i>) on the tendon regeneration failure phenotype and impact on the susceptibility to tendinopathy in Brazilian high-performance athletes. <b>Methods:</b> This case-control study was conducted with 397 high-performance athletes from different sports modalities (197 tendinopathy cases and 200 controls), and they were analyzed by validated TaqMan<sup>TM</sup> SNP genotyping assays of the SNPs <i>FBN2</i> (rs331079), <i>TNC</i> (rs2104772), and <i>MMP3</i> (rs591058). <b>Results:</b> Out of the 197 tendinopathy cases, 63% suffered from chronic tendon pain and 22% experienced more than three episodes of disease manifestation. The <i>TNC</i>-rs2104772-<i>A</i> allele was significantly associated with tendinopathy (OR: 1.4; 95% CI: 1.1-1.8), while athletes carrying the <i>MMP3</i>-rs591058-<i>T</i> allele were linked to an increased risk of more episodes of disease manifestation (OR: 1.7; 95% CI: 1.1-2.8). The <i>TNC-MMP3</i> tendon regeneration failure phenotype (<i>TNC-A/MMP3-T</i>) was associated with an increased risk of tendinopathy (OR: 1.4; 95% CI: 1.1-2.0) and episodes of disease manifestation (OR: 2.0; 95% CI: 1.2-3.5). Athletes with tendinopathy who had the <i>TNC-A/MMP3-T</i> interaction were more prone to experiencing more than three disease exacerbations (OR: 4.3; 95% CI: 1.8-10.5) compared to <i>TNC-A/TNC-C</i>. <b>Conclusions:</b> This study suggests that rs2104772 and rs591058 SNPs could be involved in the tendon regeneration failure phenotype and may influence the molecular mechanism related to the regulation of the tendon ECM during training workload.

DiagnosticsVol. 14(22)
Fernando Pessoa University (PT), Universidade do Porto (PT), Universidade do Estado do Rio de Janeiro (BR), Portuguese League Against Epilepsy (PT), Instituto Português de Oncologia Francisco Gentil (PT), IPO Porto (PT), Escola Nacional de Saúde Pública (BR), Instituto Nacional de Traumatologia e Ortopedia (BR)
Universidade do Estado do Rio de Janeiro
Good health and well-being
Openalex Percentile: Top 15%
Tendon Structure and Treatment
1.91
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.